Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSC) Short Interest Down 91.7% in August

Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSCGet Free Report) was the recipient of a significant decrease in short interest in the month of August. As of August 31st, there was short interest totaling 1,207 shares, a decrease of 91.7% from the August 15th total of 14,573 shares. Based on an average daily volume of 33,162 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the company’s shares are sold short.

Cardiac Biotech Solutions Stock Performance

Cardiac Biotech Solutions stock remained flat at $0.04 during midday trading on Thursday. 30,000 shares of the company traded hands, compared to its average volume of 13,347. Cardiac Biotech Solutions has a 52-week low of $0.02 and a 52-week high of $0.06. The stock’s fifty day moving average price is $0.03 and its 200-day moving average price is $0.04.

About Cardiac Biotech Solutions

(Get Free Report)

CB Scientific, Inc, through its US and international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.

Further Reading

Receive News & Ratings for Cardiac Biotech Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiac Biotech Solutions and related companies with MarketBeat.com's FREE daily email newsletter.